Lexaria Bioscience Corp. (LEXX)
4.44
+0.26
(+6.22%)
USD |
NASDAQ |
Nov 13, 16:00
4.43
-0.01
(-0.23%)
After-Hours: 19:59
Lexaria Bioscience Price : 4.44 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 4.32 | 4.44 | 4.19 | 4.44 | 9012.00 |
| Nov 12, 2026 | 4.300 | 4.44 | 4.02 | 4.18 | 34049.00 |
| Nov 11, 2026 | 4.64 | 4.78 | 4.44 | 4.64 | 10199.00 |
| Nov 10, 2026 | 4.53 | 4.79 | 4.50 | 4.68 | 12163.00 |
| Nov 09, 2026 | 4.63 | 4.69 | 4.40 | 4.54 | 17980.00 |
| Nov 06, 2026 | 4.098 | 4.71 | 4.098 | 4.50 | 30040.00 |
| Nov 05, 2026 | 4.07 | 4.19 | 3.87 | 4.17 | 30036.00 |
| Nov 04, 2026 | 4.01 | 4.30 | 3.875 | 4.07 | 32368.00 |
| Nov 03, 2026 | 3.79 | 4.10 | 3.70 | 4.03 | 32034.00 |
| Nov 02, 2026 | 3.50 | 3.96 | 3.445 | 3.64 | 23920.00 |
| Oct 30, 2026 | 3.63 | 3.63 | 3.09 | 3.49 | 37898.00 |
| Oct 29, 2026 | 3.38 | 3.87 | 3.30 | 3.77 | 39292.00 |
| Oct 28, 2026 | 3.13 | 3.55 | 3.065 | 3.30 | 38928.00 |
| Oct 27, 2026 | 2.91 | 3.31 | 2.91 | 3.22 | 43069.00 |
| Oct 26, 2026 | 3.08 | 3.08 | 2.83 | 2.92 | 13832.00 |
| Oct 23, 2026 | 2.98 | 3.199 | 2.84 | 3.08 | 23234.00 |
| Oct 22, 2026 | 2.74 | 3.00 | 2.510 | 2.99 | 16561.00 |
| Oct 21, 2026 | 2.68 | 2.89 | 2.516 | 2.82 | 28671.00 |
| Oct 20, 2026 | 2.60 | 2.68 | 2.46 | 2.65 | 42015.00 |
| Oct 19, 2026 | 2.79 | 2.85 | 2.430 | 2.60 | 45348.00 |
| Oct 16, 2026 | 3.19 | 3.24 | 2.81 | 2.86 | 128062.0 |
| Oct 15, 2026 | 2.74 | 3.110 | 2.74 | 2.99 | 38661.00 |
| Oct 14, 2026 | 2.81 | 2.920 | 2.43 | 2.82 | 103878.0 |
| Oct 13, 2026 | 3.29 | 3.29 | 2.69 | 2.80 | 118025.0 |
| Oct 12, 2026 | 3.18 | 3.624 | 3.18 | 3.27 | 66135.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Target Group, Inc. (Canada) | 0.0009 |
| XORTX Therapeutics, Inc. | 1.10 |
| NervGen Pharma Corp. | 1.88 |
| Milestone Pharmaceuticals, Inc. | 0.52 |
| Appili Therapeutics, Inc. | 0.002 |
Price Related Metrics
| PS Ratio | 34.40 |
| Price to Book Value | 1.548 |
| Earnings Yield | -118.9% |
| Market Cap | 7.337M |